title: Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
abstract: We report the case of a 27 year-old man developing recurrent oral aphtosis associated with fever and 8 kg of weight loss. Moderate splenomegaly was observed on physical examination and neurological and cardiac examination were normal. Laboratory findings included marked eosinophilia at 3280 giga/l. Bone marrow (BM) examination revealed a myeloproliferative syndrome with mature eosinophils. Splenectomy was performed because of a suspected nodule on the BM, the histopathology revealed a myeloid metaplasia. The diagnosis of myeloproliferative form of hypereosinophilic syndrome (HES) was made. He was treated with interferon-alfa and hydroxyurea. After two years of treatment he had no ulcer recurrence and eosinophil count was at 180 giga/l. Mucosal manifestations as a prodromal symptom of HES are rare. The histology of the lesions shows numerous eosinophils; immunohistochemical analysis confirms the presence of eosinophil peroxydase, major basic protein and eosinophil derived neurotoxin. A few cases have been described. Death occurs 11 months to 5 years after the diagnosis of oral ulcerations. The treatment consists of interferon-alfa and hydroxyurea.
authors.affiliation: Service de Médecine Interne, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite cedex, France. rimbar@voila.fr
authors.forename: R
authors.initials: R
authors.lastname: Barouky
authors.forename: L
authors.initials: L
authors.lastname: Bencharif
authors.forename: F
authors.initials: F
authors.lastname: Badet
authors.forename: G
authors.initials: G
authors.lastname: Salles
authors.forename: D
authors.initials: D
authors.lastname: Vital Durand
authors.forename: H
authors.initials: H
authors.lastname: Rousset
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D017681:Hypereosinophilic Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D016898:Interferon-alpha / Q000627:therapeutic use; D008297:Male; D012008:Recurrence; D013281:Stomatitis, Aphthous / Q000175:diagnosis / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D016898:Interferon-alpha; D006918:Hydroxyurea